Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Garlic derivative may attenuate intestinal inflammation

Dec. 7, 2004

Prometheus Laboratories to market Entocort EC

Dec. 3, 2004

Treatment begins in phase II study of Albuferon plus ribavirin for hepatitis C

Dec. 2, 2004

A new prednisolone formulation shows promise in the treatment of UC

Dec. 1, 2004

Medivir and Tibotec enter HCV license and research collaboration agreement

Dec. 1, 2004

Gilead Sciences and Achillion collaborate on HCV compounds

Dec. 1, 2004

FDA approves new indication for Nexium

Nov. 30, 2004

New formulations of tegaserod claimed by Novartis

Nov. 30, 2004

Potassium-competitive gastric acid blocker shows prolonged effect in rat model

Nov. 29, 2004

Clinical data confirm the efficacy and safety of natalizumab in Crohn's disease

Nov. 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...